I recently recommended statin therapy to a 68-year-old patient, explaining that it would reduce his risk of a major coronary event or stroke in the next 10 years from 18% to 15%. He asked, “But how will we know if it works?” I confessed we never would because success would be an uneventful walk through good health. He was not sold.
As this story shows, prevention can be a hard sell but we all know that it is also the best way to promote the health of individual patients and the population from whence they come.
Kernan WN. Keeping Faith With Patients After Stroke or Transient Ischemic Attack. JAMA Neurol. 2018;75(4):404–405. doi:10.1001/jamaneurol.2017.4027
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: